Join Forward-thinking Leaders
Elevate your expertise with tech insights, startup breakthroughs, and leadership intelligence curated for your priorities.
Elon Musk Neuralink Raises Fresh Cash At $9 B Valuation
Elon Musk’s Neuralink is currently testing its implant, which aims to help people with spinal cord injuries. Yes, you read that right, Neuralink is going to do something very amazing for those having spinal cord issues.
Summary:
1. Elon Musk Neuralink, a startup, is testing its brain implant to assist people with spinal cord injuries.
2. The company was previously valued at $5 billion in 2023. Neuralink was approved as a “breakthrough” by the US FDA and plans to use the chip for quick surgical injections of devices for obesity, autism, melancholy, and schizophrenia.
3. During the Qatar Economic Forum, Musk announced that clinical trials for the Blindsight implant will commence in 2026, aiming to provide vision to individuals who are completely blind.
According to the latest startup news, the goal of this brain implant company is to allow people to browse and post on social media, play video games, or perform other activities by simply moving a cursor on their laptop with their brain.
So, to make this possible soon, Elon Musk Neuralink raised $600 million in a deal at a $9 billion valuation before the new cash.
Although Neuralink has not responded immediately to any of the media agencies’ comments.
The startup was approximately valued at $5 billion in 2023, according to privately managed stock trades explained to media agencies. The company previously had secured $280 million in a funding round led by Peter Thiel’s Founder Fund.
Back then, in April, the company was planning to raise $500 million, according to this startup funding news
What is Elon Musk Neuralink?
While Neuralink is still testing its implant, let us walk you through what exactly it is, what it does, and how it will help people.
So, according to this latest startup news, this brain implant company is planning to help people having spinal cord problems. As the name suggests, the goal is to let disabled people use social media, post photos on versatile social media platforms, browse online, play video games, or anything else just by moving a cursor directly on the laptop with their brain.
As fascinating as this technique sounds, the more helpful it would be especially for those having a spinal cord problem. But they are still testing this to make sure that when it comes to launching this device, it will be ready to use.
Earlier this month, Elon Musk’s Neuralink was approved as a “breakthrough” by the United States FDA.
Musk has noble plans for the firm, claiming that the chip will allow healthy and impaired individuals to walk into local clinics for quick surgical injections of devices to treat obesity, autism, melancholy, and schizophrenia. He even notices them being used for web browsing and telepathy. Sounds exciting, right?
Musk’s companies’ valuations have risen dramatically over the last four years, albeit Neuralink remains one of his lesser holdings. Despite raising $180 billion in August, SpaceX was valued at $350 billion on the secondary stock market by December 2024, according to PitchBook statistics. His latest business, xAI, was worth $80 billion when it joined with X, which led to a combined corporation worth $113 billion.
Neuralink’s innovations in neurotechnology have the potential to change how people with difficulties interact with their surroundings.
The latest startup funding round not only supports the company’s financial position but also demonstrates rising investor confidence in its ability to improve healthcare and communication technology.
According to this latest startup news, Musk stated during the Qatar Economic Forum that Neuralink intends to start clinical trials for its Blindsight implant in 2026, with the goal of providing vision to people who are entirely blind. This bold ambition emphasises the broader impact of Neuralink’s work, which has the potential to provide new hope to millions of people suffering from vision loss.
Neuralink’s innovations and fundraising achievements establish it as a crucial player in the future of medical technology, with the potential to drastically enhance the lives of those with severe disabilities.
